SAB Biotherapeutics Progressing on Therapeutic for COVID-19

Click Here To View

LEADERSHIP

Executive Team

Eddie J. Sullivan, PhD
President & CEO
Co-Founder

Eddie Hamilton, DVM
Executive Chairman BOD
Co-Founder

Charles Randall, Jr.
Chief Financial Officer
Executive VP

Rick Finnegan
Chief Business Officer
Executive VP of Program Management

Melissa Ullerich 
Chief Communications Officer
Executive VP

Christoph Bausch, PhD
Chief Science Officer

Tom Luke, MD
Chief Medical Officer

Jerry Pommer, MSc, PAS, DACAWS
Chief Compliance Officer

Hua Wu, PhD
Senior VP, Vaccinology and Antibody Development

 

Executive Directors

Todd Stahl, MS
Animal Management

Kristi Egland, PhD
Molecular Genetics and Immunology

Board of Directors

Eddie Hamilton, DVM
Executive Chairman / Co-Founder
SAB Biotherapeutics

David Link
Vice Chairman
Retired Executive Vice President
Sanford Health

Eddie J. Sullivan, PhD
President, CEO & Co-Founder
SAB Biotherapeutics

Christine Hamilton
Co-Founder
Managing Partner, Christiansen Land & Cattle
Co-Owner BioDak, LLC

Bill Polvino, MD
CEO
Bridge Medicines

Scientific Advisory Board

Jim Robl, PhD
Retired Biotechnology Executive & Professor

Scott A. Lesley, Ph.D.
Vice President, Discovery Biologics
Merck Research Laboratories

Arturo Casadevall, MD, PhD
Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases
Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine

Michael Haller, MD, MS–CI
Chief, Program Director, Pediatric Endocrinology and Professor
University of Florida Medical Center

Contact Us

Headquarters:
2301 E 60th St N
Sioux Falls, SD 57104
844.268.4239

Cambridge:
245 First Street, Suite 1836
Cambridge, MA 02142
978.500.3354